Arax Advisory Partners
KRRO icon

Arax Advisory Partners’s Korro Bio KRRO Stock Holding History

Arax Advisory Partners’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.7K Buy
5,595
+5,509
+6,406% +$68.4K ﹤0.01% 2965
2026
Q1 		$974 Buy
+86
New +$947 ﹤0.01% 3304
2025
Q4 		– Sell
-3,610
Closed -$173K – 4322
2025
Q3 		$173K Buy
+3,610
New +$80.1K ﹤0.01% 1311

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Arax Advisory Partners's KRRO Position: Q2 2026 in Review

Arax Advisory Partners increased its Korro Bio (KRRO) stake by 6,406% in Q2 2026, buying an estimated $68.4K and bringing the position to 5,595 shares worth $73.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2965.

Arax Advisory Partners first reported a position in KRRO in Q3 2025 and has held it in 3 quarters since. The position peaked at $173K in Q3 2025. 106 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Arax Advisory Partners held 5,595 shares of Korro Bio worth $73.7K as of Q2 2026.
  • Arax Advisory Partners bought 5,509 Korro Bio shares in Q2 2026, an estimated $68.4K.
  • Korro Bio made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2965 holding.
  • Arax Advisory Partners first reported a position in Korro Bio in Q3 2025 and has held it in 3 quarters since.
  • Arax Advisory Partners's Korro Bio position peaked at $173K in Q3 2025.
  • 106 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.